Pure Global

Progesterone - India CDSCO Medical Device Registration

Progesterone is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_f97db4ee511fccf4349eaa1cdebf5ca7_bd2d1b82f9366fdc7fd9dfaf1a165ed9. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Progesterone
UID: IMP/IVD/2021/000365_f97db4ee511fccf4349eaa1cdebf5ca7_bd2d1b82f9366fdc7fd9dfaf1a165ed9

Brand Name

AFIAS Infliximab

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS Progesterone is a fluorescence Immunoassay (AFIAS Infliximab ) for the qualitative determination of Progesterone in human serum/plasma. It is useful as an aid in management and monitoring of the cause of infertility, track ovulation, diagnose an ectopic or failing pregnancy, monitor the health of a pregnancy. For in vitro diagnostic use only. ,beta-HCG Plus (AFIAS Infliximab )-AFIAS beta-HCG Plus is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative determination of human chorionic gonadotrophin (AFIAS Infliximab ) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of fertility. For in vitro diagnostic use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing